World's Best Scientists 2026 revealed!
Steven Simoens

Steven Simoens

Award Badge
Social Sciences and Humanities
Belgium
2026

D-Index & Metrics

Social Sciences and Humanities

D-Index
64
Citations
16713
World Ranking
1098
National Ranking
9

Steven Simoens publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where Steven Simoens sits on this spectrum.

44–53 publications: 28 scientists 54–63 publications: 61 scientists 64–73 publications: 161 scientists 74–83 publications: 225 scientists 84–93 publications: 301 scientists 94–103 publications: 390 scientists 104–113 publications: 406 scientists 114–123 publications: 474 scientists 124–133 publications: 453 scientists 134–143 publications: 434 scientists 144–153 publications: 407 scientists 154–163 publications: 411 scientists 164–173 publications: 391 scientists 174–183 publications: 313 scientists 184–193 publications: 319 scientists 194–203 publications: 304 scientists 204–213 publications: 285 scientists 214–223 publications: 246 scientists 224–233 publications: 213 scientists 234–243 publications: 170 scientists 244–253 publications: 167 scientists 254–263 publications: 162 scientists 264–273 publications: 138 scientists 274–283 publications: 138 scientists 284–293 publications: 113 scientists 294–303 publications: 106 scientists 304–313 publications: 95 scientists 314–323 publications: 101 scientists 324–333 publications: 81 scientists 334–343 publications: 69 scientists 344–353 publications: 56 scientists 354–363 publications: 36 scientists 364–373 publications: 42 scientists 374–383 publications: 41 scientists 384–393 publications: 44 scientists 394–403 publications: 27 scientists 404–413 publications: 30 scientists 414–423 publications: 20 scientists 424–433 publications: 29 scientists 434–443 publications: 29 scientists 444–453 publications: 25 scientists 454–463 publications: 19 scientists 464–473 publications: 21 scientists 474–483 publications: 11 scientists 484–493 publications: 17 scientists 494–503 publications: 7 scientists 504–513 publications: 6 scientists 514–523 publications: 12 scientists 524–533 publications: 10 scientists 534–543 publications: 7 scientists 544–553 publications: 6 scientists 554–563 publications: 12 scientists 564–569 publications: 8 scientists 570+ publications: 100 scientists
44 publications 570+

This scientist: 548 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 570 publications or more.

Steven Simoens D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where Steven Simoens sits on this spectrum.

30 D-Index: 177 scientists 31 D-Index: 210 scientists 32 D-Index: 222 scientists 33 D-Index: 188 scientists 34 D-Index: 181 scientists 35 D-Index: 243 scientists 36 D-Index: 261 scientists 37 D-Index: 272 scientists 38 D-Index: 278 scientists 39 D-Index: 300 scientists 40 D-Index: 297 scientists 41 D-Index: 308 scientists 42 D-Index: 313 scientists 43 D-Index: 300 scientists 44 D-Index: 269 scientists 45 D-Index: 260 scientists 46 D-Index: 228 scientists 47 D-Index: 251 scientists 48 D-Index: 203 scientists 49 D-Index: 186 scientists 50 D-Index: 187 scientists 51 D-Index: 166 scientists 52 D-Index: 138 scientists 53 D-Index: 141 scientists 54 D-Index: 131 scientists 55 D-Index: 137 scientists 56 D-Index: 109 scientists 57 D-Index: 129 scientists 58 D-Index: 95 scientists 59 D-Index: 105 scientists 60 D-Index: 106 scientists 61 D-Index: 86 scientists 62 D-Index: 94 scientists 63 D-Index: 77 scientists 64 D-Index: 79 scientists 65 D-Index: 59 scientists 66 D-Index: 68 scientists 67 D-Index: 51 scientists 68 D-Index: 49 scientists 69 D-Index: 40 scientists 70 D-Index: 43 scientists 71 D-Index: 40 scientists 72 D-Index: 50 scientists 73 D-Index: 46 scientists 74 D-Index: 43 scientists 75 D-Index: 45 scientists 76 D-Index: 45 scientists 77 D-Index: 30 scientists 78 D-Index: 25 scientists 79 D-Index: 31 scientists 80 D-Index: 29 scientists 81 D-Index: 18 scientists 82 D-Index: 21 scientists 83 D-Index: 26 scientists 84 D-Index: 15 scientists 85 D-Index: 15 scientists 86 D-Index: 19 scientists 87 D-Index: 19 scientists 88 D-Index: 12 scientists 89 D-Index: 7 scientists 90 D-Index: 19 scientists 91 D-Index: 20 scientists 92 D-Index: 13 scientists 93 D-Index: 9 scientists 94 D-Index: 13 scientists 95 D-Index: 8 scientists 96 D-Index: 7 scientists 97 D-Index: 6 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100+ D-Index: 97 scientists
30 D-Index 100+

This scientist: 64 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 100 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Social Sciences and Humanities in Belgium Leader Award
  • 2025 - Research.com Social Sciences and Humanities in Belgium Leader Award
  • 2023 - Research.com Social Sciences and Humanities in Belgium Leader Award
  • 2022 - Research.com Social Sciences and Humanities in Belgium Leader Award

Overview

Steven Simoens is affiliated with KU Leuven in Belgium and has a diverse research portfolio spanning economics, medicine, and pharmaceutical studies. Their work predominantly focuses on the intersection of health systems, economic evaluations, and pharmaceutical policy.

The main fields of study for Steven Simoens include Economics, Econometrics and Finance, and Medicine. Within these broad fields, their subfield expertise covers Economics and Econometrics, Immunology, Pediatrics, Perinatology and Child Health, Physiology, and Epidemiology.

Their research concentrates on several main topics, notably Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, and Biosimilars and Bioanalytical Methods. Additional areas of study include Pharmaceutical studies and practices, Biomedical Ethics and Regulation, Intellectual Property and Patents, and the Economic and Financial Impacts of Cancer.

Frequent co-authors collaborating with Steven Simoens are:

  • Isabelle Huys (76 joint publications)
  • Arnold G. Vulto (42 joint publications)
  • Liese Barbier (18 joint publications)
  • Yannick Vandenplas (14 joint publications)
  • Walter Van Dyck (14 joint publications)

Steven Simoens has published extensively in several academic journals. Their most frequent publication venues include:

  • Value in Health (31 publications)
  • Frontiers in Pharmacology (26 publications)
  • Expert Review of Pharmacoeconomics & Outcomes Research (9 publications)
  • BioDrugs (7 publications)
  • Pharmaceuticals (6 publications)

Some of their recent papers are:

  • "The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review," 2020, Clinical Pharmacology & Therapeutics
  • "The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases," 2020, Drugs
  • "Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications," 2021, Expert Review of Pharmacoeconomics & Outcomes Research
  • "R&D Costs of New Medicines: A Landscape Analysis," 2021, Frontiers in Medicine
  • "European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption," 2020, BioDrugs

Best Publications

  • The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres

    Steven Simoens;Gerard Dunselman;Carmen Dirksen;Lone Hummelshoj

  • Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

    Niels Vande Casteele;Marc Ferrante;Gert Van Assche;Vera Ballet

  • The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey

    A. A. De Graaff;T. M. D'hooghe;G. A J Dunselman;C. D. Dirksen

  • Endometriosis: cost estimates and methodological perspective

    Steven Simoens;L Hummelshoj;Thomas D'Hooghe

  • Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review.

    T Zuberbier;J Lötvall;Steven Simoens;S Subramanian

  • Pricing and reimbursement of orphan drugs: the need for more transparency

    Steven Simoens

  • Impact, regulation and health policy implications of physician migration in OECD countries.

    Mélanie Bourassa Forcier;Steven Simoens;Antonio Giuffrida

  • Policies for biosimilar uptake in Europe: An overview.

    Evelien Moorkens;Arnold G. Vulto;Isabelle Huys;Pieter Dylst

  • Economic effects of clinical pharmacy interventions: a literature review.

    Thomas De Rijdt;Ludo Willems;Steven Simoens

  • Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

    Wills Hughes-Wilson;Ana Palma;Ad Schuurman;Steven Simoens

  • Sustaining generic medicines markets in Europe

    Steven Simoens;Sandra De Coster

  • Job Satisfaction and Quitting Intentions: A Structural Model of British General Practitioners

    Anthony Scott;Hugh Gravelle;Steven Simoens;Chris Bojke

  • Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.

    Brian Barr Godman;Anna Bucsics;Patricia Vella Bonanno;Wija Oortwijn;Wija Oortwijn

  • Outrageous prices of orphan drugs: a call for collaboration

    Lucio Luzzatto;Hanna I Hyry;Arrigo Schieppati;Enrico Costa

  • The Supply of Physician Services in OECD Countries

    Unknown

  • A comparative study of European rare disease and orphan drug markets.

    Alain Denis;Lut Mergaert;Christel Fostier;Irina Cleemput

  • Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

    Kim Pauwels;Isabelle Huys;Sabine Vogler;Minne Casteels

  • Body composition, volumetric and areal bone parameters in male-to-female transsexual persons.

    Unknown

  • Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries

    Thomas Morel;Francis Arickx;Gustaf Befrits;Paolo Siviero

  • Biosimilar medicines and cost-effectiveness

    Steven Simoens

  • Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

    Kim Pauwels;Isabelle Huys;Minne Casteels;Steven Simoens

  • Tackling Nurse Shortages in OECD Countries

    Unknown

  • Outrageous prices of orphan drugs: a call for collaboration

    Lucio Luzzatto;Hanna I. Hyry;Arrigo Schieppati;Enrico Costa

Frequent Co-Authors

Brian Godman
Brian Godman University of Strathclyde
Thomas D'Hooghe
Thomas D'Hooghe Yale University
Paul Declerck
Paul Declerck KU Leuven
Maarten J. Postma
Maarten J. Postma University of Groningen
Marc Decramer
Marc Decramer KU Leuven
Stephen Campbell
Stephen Campbell University of Manchester
Silvio Garattini
Silvio Garattini Mario Negri Institute for Pharmacological Research
Mondher Toumi
Mondher Toumi Aix-Marseille University
Jeff Richardson
Jeff Richardson Monash University
Erik Nord
Erik Nord Norwegian Institute of Public Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Social Sciences and Humanities in the USA can open many doors, especially with the growing accessibility of online programs. Online degrees offer the flexibility to balance study, work, and personal commitments while pursuing your passion. A popular option for students interested in human behavior and mental health is a psychology online degree. These programs can lead to careers in counseling, research, and more.

If your interests lie in social work, you might want to explore online msw programs, which prepare students for impactful roles in communities, clinics, and various organizational settings. For those aiming for clinical practice at the doctoral level, accredited online psyd programs provide rigorous training pathways, recognized by employers and licensing boards.

Interested in family therapy? accelerated mft programs online can help you complete your credential quickly, so you can start supporting families and couples in need sooner. Regardless of your chosen path, these online options make it easier than ever to advance your education and start a meaningful career in the Social Sciences and Humanities.

Best Scientists Citing Steven Simoens

Trending Scientists

Recently Published Articles